Semaglotide and the World Health Organization's Essential Medicines List

Right now the question is whether semaglotide which is what ozempic and vigor we are you know made of should be included in the World Health Organization's essential medicines list. Novo Nordisk along with Eli Lilly which also has a slew of anti obesity drugs coming into the market are spending roughly 10 million dollars annually on lobbying of the US government to do just that. A primary focus of their lobbying is the proposed Treat and Reduce Obesity Act that would require Medicare to cover the chronic weight management drugs that treat obesity.